Request Demo
Last update 23 Jan 2025
Semaglutide biosimilar (Livzon Group)
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Recombinant polypeptide, Biosimilar |
Synonyms- |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 50953
The sequence is quoted from: *****
Related
3
Clinical Trials associated with Semaglutide biosimilar (Livzon Group)CTR20243356
司美格鲁肽注射液与Wegovy®在中国肥胖成人患者中多中心、随机、开放、平行、阳性对照的III期临床试验
[Translation] A multicenter, randomized, open, parallel, positive-controlled Phase III clinical trial of semaglutide injection and Wegovy® in obese adult patients in China
CTR20222962
司美格鲁肽注射液与诺和泰®在2型糖尿病患者中多中心、随机、开放、平行对照的临床有效性和安全性对比试验。
[Translation] A multicenter, randomized, open, parallel-controlled comparative trial of the clinical efficacy and safety of semaglutide injection and Novotel® in patients with type 2 diabetes.
CTR20222452
司美格鲁肽注射液与诺和泰®在健康受试者中单次给药、随机、开放、平行对照的药代动力学对比试验
[Translation] A single-dose, randomized, open-label, parallel-controlled pharmacokinetic comparison study between semaglutide injection and Novotec® in healthy subjects
100 Clinical Results associated with Semaglutide biosimilar (Livzon Group)
Login to view more data
100 Translational Medicine associated with Semaglutide biosimilar (Livzon Group)
Login to view more data
100 Patents (Medical) associated with Semaglutide biosimilar (Livzon Group)
Login to view more data
100 Deals associated with Semaglutide biosimilar (Livzon Group)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | NDA/BLA | CN | 13 Jun 2024 | |
| Obesity | Phase 3 | CN | 13 Sep 2024 | |
| Cardiovascular Diseases | Phase 3 | CN | 12 Jan 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | - | - | mipkodfycz(jmyukrflhu) = ecsrzpmyti yvxoecfwng (yzfhlgwijg ) View more | - | 01 Jun 2021 | ||
mipkodfycz(jmyukrflhu) = pedawjymtc yvxoecfwng (yzfhlgwijg ) View more | |||||||
Not Applicable | - | - | przlrjtamp(kewpokqfyp) = llubtaxorg hqeuwrsrhl (mehnjsakdl ) | - | 01 Jun 2021 | ||
przlrjtamp(kewpokqfyp) = oufntfbqyl hqeuwrsrhl (mehnjsakdl ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free